에 대한 최신 뉴스 Suzano (NYSE:SUZ) 주식

Suzano

Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.

Mesa,,Az,-,Sept,08,2024:,Tesla,Ev,Cars,Parked

Equities

Large Cap

News

Movers

CIEN

DOCU

KVUE

LULU

TSLA

테슬라, 룰루레몬 등 지난주 급락한 대형주 10종목 (6월 2일~6일)

Moderna

APTV

BGNE

BIRK

MRNA

POOL

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 월그린스 부츠 얼라이언스(NASDAQ:WBA)의 주가는 회사가 혼합된 3분기 실적을 보고하고 2024년 지침을 컨센서스 추정치보다 낮게 낮춘 후 24.12% 하락했다. 분석가들은 주식에 대한 가격 예측을 하향 조정했다.

모더나와 월그린스는 지난주 최악의 성과를 보인 10대 대형주 중 일부 (6월 23일-6월 29일)

Rivian7

ALNY

CVNA

FTAI

MSTR

RDDT

RIVN

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 리비안 오토모티브(NASDAQ:RIVN)는 회사가 생산량을 단순화하고 비용을 절감했으며 폭스바겐과의 합작 투자 계획을 발표했다는 보도가 나온 후 지난주 주가가 30.04% 급등했다. 

리비안과 카바나는 지난주 최고의 성과를 보인 10대 대형주 중 일부 (6월 23일-6월 29일)

Suzano S.A. American Depositary Shares (each representing One Ordinary Share)

Suzano SA

Sulzer AG

Suzuken Co Ltd

Suzuki Motor Corp

SUZUKI MOTOR CO UNSP/ADR by Suzuki Motor Co.

Financing

AMC Enters Transaction Support Agreement With Creditor Groups; Includes ~$223.3M Of New Money Financing, Immediate Conversion Of $143.0M Of 6.00%/8.00% Senior Secured Exchangeable Notes due 2030 And Resolution Of Litigation With Certain Holders Of 7.5% Senior Secured Notes due 2029

Canaccord Genuity analyst Richard Close initiates coverage on Omada Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMDA#NASDAQ">OMDA</a>) with a Buy rating and announces Price Target of $27.

Price Target

Initiation

Analyst Ratings

OMDA

Canaccord Genuity Initiates Coverage On Omada Health with Buy Rating, Announces Price Target of $27

QMCO: -15% &#x7C; <a href="https://www.benzinga.com//node/46181747">Quantum shares are trading lower after the company delayed its FY25 10-K filing due to an ongoing review of its accounting.</a>
&nbsp;
CLRO: 140% &#x7C; <a href="https://www.benzinga.com//node/46182384">ClearOne Declares One-Time Special Stock Dividend On The Co's Issued And Outstanding Shares Of Common Stock And Any Common Stock Equivalents With Dividend Rights To Legacy Stockholders With A 100% Stake In The Proceeds From Any Eventual Sale Of All Or Substantially All Of The Co's Current Assets And Operations In One Or More Transactions</a>
&nbsp;
GPUS: 117% &#x7C; <a href="https://www.benzinga.com//node/46190175">Hyperscale Data's Ault Markets Plans To Launch Decentralized Cryptocurrency Exchange To Be Based In US, With Headquarters In Las Vegas, Nevada</a>

Trading Ideas

CLRO

GPUS

QMCO

Market-Moving News for July 1st

Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the pricing of its underwritten public offering of $100 million of shares of its common stock. Nektar is selling 4,255,320 shares of common stock in the offering. The shares of common stock are being sold at a public offering price of $23.50 per share. The gross proceeds to Nektar from the offering are expected to be approximately $100 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, Nektar has granted the underwriters a 30-day option to purchase up to an additional 638,298 shares of its common stock at the public offering price per share, less underwriting discounts and commissions.&nbsp;All of the securities being sold in this offering are being offered by Nektar. The offering is expected to close on July 2, 2025, subject to the satisfaction of customary conditions.
Nektar intends to use the net proceeds from the offering for general corporate purposes, which may include research and development, clinical development and manufacturing costs to support the advancement of its drug candidates, as well as other general corporate purposes.
 &nbsp;

Offerings

NKTR

Nektar Therapeutics Prices Underwritten Public Offering Of $100M Of Shares At $23.50/Shr

Nouveau Monde Graphite Pays Q2 2025 Accrued Interest To Investissement Québec via Share Issuance

UK's CMA Considering Whether Global Payments / Worldpay Merger Will Reduce Competition Within Any Market

Pursuant to the Agreement and subject to the completion of certain closing procedures, the investor has agreed to exchange approximately $28 million in outstanding Senior Notes, consisting of $8 million in December 2026 notes, $2 million in January 2028 notes, and $18 million in August 2028 notes, for $13 million in newly issued 8.00% Senior Secured Second Lien Notes due January 1, 2028 (the "Notes"). In addition, the Company is issuing to the investor warrants to purchase an aggregate of approximately 52,000 common shares at an exercise price of&nbsp;$10.00&nbsp;per share. The warrants are exercisable for a period of seven years from the issuance date.

RILY

B. Riley Financial Reduces Total Outstanding Debt by ~$15M Through Private Bond Exchange Agreement

Ark Invest, a leading investment management firm led by Cathie Wood, has highlighted a pivotal development set to bridge the world of blockchain-based capital with the substantial U.S. mortgage market.
What Happened: According to Nick Grous, an associate portfolio manager at Ark Invest, the recent directive from the Federal Housing Finance Agency (FHFA) instructing Fannie Mae (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FNMA#OTC">FNMA</a>) and Freddie Mac (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FMCC#OTC">FMCC</a>) to consider cryptocurrency holdings, such as Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), for mortgage loan risk assessments marks &#8220;crypto's first step into U.S. housing: from wallets to mortgages.&#8221;
&#8220;This directive introduces a novel bridge between blockchain-based capital and the $12 trillion U.S. mortgage market,&#8221; Grous notes.
Looking at the potential scale, Grous references iEmergent's 2024 Home Mortgage Disclosure Act (HMDA) data, which reported around &#8220;6 million mortgage originations in the U.S. last year, valued at $1.82 trillion.&#8221;
Based on an average loan size of approximately &#8220;$340,000,&#8221; Ark Invest&#8217;s analysis suggests that &#8220;if just 5% of mortgage borrowers included crypto-based assets in their applications, ~305,000 would qualify for a mortgage in this new framework—supporting $100 billion in originations.&#8221;
He further projects that &#8220;each additional percentage point of adoption would increase mortgage loan volume by ~$20 billion.&#8221;
This regulatory development, according to Ark Invest, &#8220;aligns with ARK's thesis that crypto will reshape legacy financial systems with greater transparency, automation, and interoperability.&#8221;
See Also: <a href="https://www.benzinga.com/crypto/25/06/46089173/michael-saylor-offers-btc-credit-model-as-bill-pulte-pushes-crypto-for-fannie-mae-freddie-mac-could-bitcoin-soon-count-toward-mortgage-qualification">Michael Saylor Offers BTC Credit Model As Bill Pulte Pushes Crypto For Fannie Mae, Freddie Mac: Could Bitcoin Soon Count Toward Mortgage Qualification? </a>
Why It Matters: The FHFA&#8217;s directive, issued last week, represents a significant shift.
It allows for the inclusion of cryptocurrency holdings, specifically &#8220;only those held on U.S.-regulated centralized exchanges,&#8221; as assets in single-family mortgage loan risk assessments.
Crucially, this directive &#8220;does not require converting crypto to U.S. dollars and does not include crypto held in self-custodied wallets.&#8221;
It also mandates &#8220;risk controls, like accounting for crypto market volatility and limiting how much crypto can count toward reserves,&#8221; signaling a cautious yet forward-looking approach to integration.
Last week, Strategy Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) Michael Saylor stepped forward to offer Strategy&#8217;s (formerly MicroStrategy) <a href="http://46089173/michael-saylor-offers-btc-credit-model-as-bill-pulte-pushes-crypto-for-fannie-mae-freddie-mac-could-bitcoin-soon-count-toward-mortgage-qualification">Bitcoin Credit Model</a> to support the initiative. 
Meanwhile, the Bitcoin Policy Institute <a href="https://www.btcpolicy.org/articles/the-powerful-fannie-mae-policy-change-to-unlock-bitcoin-based-mortgages">hails</a> this as a potential game-changer, stating that a tweak to Fannie Mae&#8217;s Selling Guide to recognize Bitcoin as collateral could unlock homeownership for millions, aligning with Donald Trump&#8217;s vision to make the U.S. the &#8220;Bitcoin Capital of the planet.&#8221;
Price Action: Fannie Mae shares ended 1.95% lower on Monday. It has risen by 177.33% on a year-to-date basis and 553.42% over the past year.
On the other hand, Freddie Mac declined 1.55% on Monday, and it has risen by 144.51% on a year-to-date basis and 505.88% over the past year.
After hitting fresh records on Friday and Monday, on Tuesday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were lower in premarket. The SPY was down 0.18% at $616.74, while the QQQ declined 0.26% to $550.18, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46189081/what-are-stock-tokens-and-how-to-trade-them-robinhoods-new-offering-merges-owning-stocks-with-blockchain-tech-heres-how-it-works">What Are Stock Tokens And How To Trade Them? Robinhood&#8217;s New Offering Merges Owning Stocks With Blockchain Tech: Here&#8217;s How It Works</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. Image Via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

$ETH

FMCC

FNMA

Bitcoin, Ethereum Could Soon Help You Get A Mortgage Now — Cathie Wood's Ark Invest Sees $12 Trillion Opportunity After FHFA Move

Cash proceeds will be allocated to debt repayment, resulting in a pro-forma leverage ratio below 2.0x after the closing, to be further reduced with the previously announced planned divestiture of Greif's timberland business. These actions will enable future disciplined capital redeployment and optionality for strategic growth investments.
Strategic Rationale:
<ul>
<li>Further Positions Greif as a Packaging Leader</li>
<li>Allows Greif to Deliver More Durable Earnings</li>
<li>Enhances Capital Utilization, Reducing Recurring Capital Needs</li>
<li>Enables Debt Reduction, Unlocking Value-Creation Opportunities</li>
</ul>

Greif To Sell Containerboard Unit And CorrChoice Network To Packaging Corporation Of America For $1.8B

YY Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYGH#NASDAQ">YYGH</a>) ("YY Group," "YYGH," or the "Company"), a global leader in on-demand workforce solutions and integrated facility management (IFM), is pleased to announce its acquisition of Pesticide Pest Control Pte. Ltd., a Singapore-based pest control company with over 30 years of operational history.
The company will be rebranded as Pest Fighter Management Pte. Ltd., marking the beginning of its next growth phase under YY Group's integrated IFM platform. The acquisition is expected to close on July 1, 2025.
Revenue Trajectory and Outlook
YY Group's integration of Pest Fighter is expected to contribute significantly to its growth trajectory. The Group projects annual revenue to increase from S$26.3 million in 2023 to S$96.0 million by 2028, representing a compound annual growth rate of 29.1% substantially outpacing industry averages of 5% to 8% annually.
Pest Fighter is anticipated to enhance client retention, strengthen the value of bundled services, and improve profit margins, further anchoring YY Group's ability to deliver comprehensive facility solutions.

YYGH

YY Group Acquires Pesticide Pest Control For Undisclosed Terms; Co To Be Rebranded As Pest Fighter Management Pte. Ltd.

Greif To Sell Containerboard Business to Packaging Corp. for $1.8B in All-Cash Deal; Proceeds to Cut Debt, Sharpen Portfolio Focus

NIP Group Inc. ("NIPG" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>), a leading digital entertainment company, today announced it has entered into a definitive asset-purchase agreement (the "Agreement") to acquire on-rack crypto mining machines (the "Products") from Fortune Peak Limited and Apex Cyber Capital Limited (together, the "Sellers"). These Products are currently used for Bitcoin mining and are expected to begin generating significant Bitcoin mining revenue for the Company upon closing of the acquisition. To support this initiative, NIPG has established a dedicated Digital Computing Division to manage the operations of the acquired Products and lead the future development of the Company's compute infrastructure capabilities. Importantly, this transaction marks a strategic extension of NIPG's business into the digital infrastructure space.
The Products, consisting of data center capacity with a combined hash rate of 3.11 EH/s, are currently utilized for Bitcoin mining operations with expected production of approximately 60 Bitcoins per month, and will continue operating immediately after closing of the proposed transaction. Under the terms of the Agreement, NIPG will pay the consideration for the Products through issuance of approximately 119,553,439 Class A ordinary shares of the Company to the Sellers. In connection with the consummation of the proposed transactions contemplated by the Agreement, the Company and the Sellers will also enter into an investor rights agreement to define certain rights and obligations among them with respect to the Company.
The closing of the proposed transaction is expected to occur on or before September 30, 2025, and is subject to customary closing conditions. There can be no assurance that the closing conditions will be satisfied nor that the proposed transaction will be completed before that date or at all.

NIPG

NIP Group to Acquire Bitcoin Mining Machines, Expands Into Digital Infrastructure

Rosenblatt analyst Kevin Cassidy maintains Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) with a Neutral and maintains $3 price target.

BZAI

Rosenblatt Maintains Neutral on Blaize Holdings, Maintains $3 Price Target

Investar Holding Corporation ("Investar") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISTR#NASDAQ">ISTR</a>), the holding company for Investar Bank, N.A., and Wichita Falls Bancshares, Inc. ("Wichita Falls"), the holding company for First National Bank, Wichita Falls, Texas, jointly announced today that they have entered into a definitive agreement pursuant to which Investar will acquire Wichita Falls for cash and stock consideration. In connection with the proposed acquisition, Investar also announced today a private placement of $32.5 million of its newly designated 6.5% Series A Non-Cumulative Perpetual Convertible Preferred Stock.
The definitive agreement has been unanimously approved by the boards of directors of Investar and Wichita Falls, and the closing of the transaction, which is expected to occur in the fourth quarter of 2025, is subject to customary conditions, including shareholder and regulatory approvals. The definitive agreement provides that upon the closing of the transaction, Wichita Falls shareholders will be entitled to receive an aggregate of 3,955,334 shares of Investar common stock, and cash consideration of $7.2 million, in exchange for their shares, subject to adjustment under certain circumstances. Based on the closing price of $19.32 for Investar common stock on June 30, 2025, the transaction would result in aggregate consideration of approximately $83.6 million, or $134.67 per share of Wichita Falls common stock.
&nbsp;

ISTR

Investar Holding Corporation Announced Merger with Wichita Falls Bancshares

PSEC

Prospect Capital Closes $115M All-Cash Acquisition Of QC Holdings; Company To Remain Headquartered In Kansas Under Existing Leadership

BLCO

Bausch + Lomb Uses Survey Insights And Patient Input To Clarify Dry Eye Realities

Adagene Inc. ("Adagene or the Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAG#NASDAQ">ADAG</a>), a company transforming the discovery and development of novel antibody-based therapies, today announced strategic investment and option exercise by Sanofi (Euronext: SAN FP).
Sanofi has agreed to make strategic investment of up to US$25 million in Adagene. The Company plans to use the proceeds to fund its research and development activities, including clinical development of muzastotug (ADG126), an anti-CTLA-4 SAFEbody, through a randomized phase 2 trial in microsatellite stable colorectal cancer (MSS CRC).
To further explore the clinical potential of muzastotug, Adagene will supply Sanofi with muzastotug to evaluate the safety, efficacy, pharmacokinetics and biomarker data in combination with other anticancer therapies in over 100 patients in a phase 1/2 clinical trial in advanced solid tumors. Adagene continues to own worldwide commercial rights to muzastotug.
Sanofi has also exercised its option to select a third SAFEbody discovery program, utilizing Adagene's proprietary masking technology and antibody engineering expertise. The bispecific therapeutic, with undisclosed targets, will be engineered by Adagene and induces an option exercise fee, as well as milestones and royalties as per the 2022 partnership agreement with Adagene.

ADAG

Sanofi Invests Up to $25M in Adagene to Advance Cancer Drug Trials

NVCR

Novocure To Present Final PANOVA-3 Secondary Data At ESMO GI 2025; TTFields Shows Pain Relief, QoL Gains In Pancreatic Cancer

<ul>
<li>Under the companies' 2020 collaboration agreement, Apellis is eligible for tiered royalties on ex-U.S. sales of Aspaveli ranging from high teens to high twenties. Apellis retains exclusive commercialization rights for systemic pegcetacoplan in the United States, where the product is marketed as EMPAVELI.</li>
<li>Apellis to receive $275 million upfront and up to $25 million in milestone payments upon EMA approval in C3G and IC-MPGN</li>
<li>Non-dilutive financing further strengthens Apellis' balance sheet</li>
<li>Apellis retains full U.S. commercialization rights for systemic pegcetacoplan</li>
<li>Transaction underscores shared confidence in the meaningful growth potential in rare kidney diseases</li>
</ul>

Biotech

Health Care

Contracts

General

APLS

Apellis Pharmaceuticals Announced A Capped Royalty Purchase Agreement With Sobi Under Which Apellis Will Receive Up To $300M In Exchange For 90% Of Apellis' Future Ex-U.S. Royalties For Aspaveli (Systemic Pegcetacoplan)

QBTS

D-Wave Completes $400M ATM Equity Offering; Explores Strategic Acquisitions To Expand Quantum Leadership

Press Releases

Suzano Starts Operation of the World's Largest Pulp Production Line

Suzano reports Adjusted EBITDA of R$6.3 billion in the second quarter of 2024

Suzano completes purchase of 15% stake in Lenzing AG

Suzano Completes the Acquisition of Two U.S. Industrial Facilities from Pactiv Evergreen

Suzano Reports Operating Cash Generation of R$4.4 Billion in the Third Quarter of 2024

Suzano sets sales record in 2024 with new mill in Mato Grosso do Sul state and acquisition in the U.S.

Suzano 2024 Annual Report on Form 20-F

Suzano Reports Record First-Quarter Revenue

Kimberly-Clark Announces Major Step Forward in its Powering Care Transformation

Suzano and Kimberly-Clark Announce the Creation of a Global Tissue Company Operating in Over 70 Countries

Clearwater Paper Corporation Common Stock

Clearwater Paper

IT Tech Packaging

Magnera

Mercer Intl

Sylvamo

지난주 가장 저조한 성과를 보인 10개 대형주는 다음과 같다.
<ol class="wp-block-list">
<li>룰루레몬 애슬레티카(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) 주가는 1분기 실적을 발표했고 16.23% 하락했다. <a href="https://www.benzinga.com//node/45819605" target="_blank" rel="noreferrer noopener">애널리스트들은 목표주가를 수정했다</a>.</li>
<li>브라운 포먼(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) 주식은 무역 전쟁과 관세로 인해 <a href="https://www.benzinga.com//node/45793814" target="_blank" rel="noreferrer noopener">예상보다 저조한 재무 실적</a>을 보고한 후 15.69% 폭락했다. 애널리스트들은 주식에 대한<a href="https://www.benzinga.com/quote/bf-b/analyst-ratings" target="_blank" rel="noreferrer noopener"> 목표주가를 하향 조정했다.</a></li>
<li>도큐사인(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) 주식은 1분기 실적 발표 후 15.04% 하락했다. 애널리스트들이 <a href="https://www.benzinga.com//node/45818750" target="_blank" rel="noreferrer noopener">목표주가를 수정했다</a>.</li>
<li>테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) 주가는 지난주 14.81% 하락했다. 이는 일론 머스크의 특별공무원직 퇴임과 더불어 <a href="https://www.benzinga.com//node/45805173" target="_blank" rel="noreferrer noopener">트럼프 대통령과의 갈등</a> 때문일 것이다.</li>
<li>시에나(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>)는 예상보다 안 좋은 <a href="https://www.benzinga.com//node/45788812" target="_blank" rel="noreferrer noopener">2분기 실적</a>을 보고했고 지난주 9.17% 하락했다. 여러 애널리스트들이 <a href="https://www.benzinga.com//node/45822276" target="_blank" rel="noreferrer noopener">시에나의 목표주가를 수정했다.</a></li>
<li>켄뷰(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) 주가는 8.97% 하락했다.</li>
<li>킴벌리클라크(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NASDAQ">KMB</a>) 주가는 7.10% 하락했다. 지난주, 수자노(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUZ#NYSE">SUZ</a>)가 킴벌리클라크와 <a href="https://www.benzinga.com//node/45797473" target="_blank" rel="noreferrer noopener">34억 달러 규모의 티슈 거래를 성사시켰다</a>.</li>
<li>피어슨(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSO#NYSE">PSO</a>) 주가는 지난주 6.08% 하락했다.</li>
<li>팩트셋 리서치 시스템즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) 주가는 5.65% 하락했다. 이사회는 사노크 비스와나탄(Sanoke Viswanathan)을 CEO로 임명했으며, <a href="https://www.benzinga.com//node/45742153" target="_blank" rel="noreferrer noopener">2025년 9월 초부터 효력이 발생한다</a>.</li>
<li>아서 J 갤러거(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) 주식은 지난주 5.38% 하락했다.</li>
</ol>
이미지 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
<ol>
<li>월그린스 부츠 얼라이언스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)의 주가는 회사가 혼합된 3분기 실적을 보고하고 2024년 지침을 <a href="https://www.benzinga.com//node/39523397" target="_blank" rel="noreferrer noopener">컨센서스 추정치</a>보다 낮게 낮춘 후 24.12% 하락했다. 분석가들은 주식에 대한 <a href="https://www.benzinga.com/quote/wba/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">가격 예측</a>을 하향 조정했다.</li>
<li>플로어 앤 데코 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FND#NYSE">FND</a>)의 주식은 예상보다 나쁜 5월 주택판매 경제 데이터에 대한 반응으로 13.41% 급락했다.</li>
<li>모더나(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>)의 주가는 회사의 RSV 백신이 <a href="https://www.benzinga.com//node/39508239" target="_blank" rel="noreferrer noopener">50%의 효능을 보인</a> 이후 11.76% 급락했다.</li>
<li>버켄스탁 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>)의 주식은 회사가 매각 주주가 최대 1,400만 주 보통주를 <a href="https://www.benzinga.com//node/39467369" target="_blank" rel="noreferrer noopener">공모</a>한다고 발표한 후 주가는 10.86% 하락했다.</li>
<li>베이진(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGNE#NASDAQ">BGNE</a>)의 주식은 지난주에 9.70% 하락했다.</li>
<li>풀 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POOL#NASDAQ">POOL</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/39484866" target="_blank" rel="noreferrer noopener">FY24 EPS 가이던스를 낮춘 </a>이후 9.19% 떨어졌다.</li>
<li>징동닷컴(JD닷컴)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>)의 주식은 미국이 <a href="https://www.benzinga.com//node/39521291" target="_blank" rel="noreferrer noopener">중국 기술에 대한 투자</a>를 억제하는 규정을 발표한 이후 8.89% 하락했다.</li>
<li>에코페트롤(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EC#NYSE">EC</a>)의 주식은 8.02% 급락했다</li>
<li>인터내셔널 페이퍼(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>)의 주식은 수자노(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUZ#NYSE">SUZ</a>)가 <a href="https://www.benzinga.com//node/39519611" target="_blank" rel="noreferrer noopener">인수 거래를 중단</a>하기로 한 이후 7.98% 하락했다.</li>
<li>마이크론 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>)의 주식은 지난 주 <a href="https://www.benzinga.com//node/39520174" target="_blank" rel="noreferrer noopener">3분기 실적과 4분기 전망</a>에 대한 정보가 나온 이후 7.62% 하락했다.</li>
</ol>
다음 기사 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/%eb%a6%ac%eb%b9%84%ec%95%88%ea%b3%bc-%ec%b9%b4%eb%b0%94%eb%82%98%eb%8a%94-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ea%b3%a0%ec%9d%98-%ec%84%b1%ea%b3%bc%eb%a5%bc-%eb%b3%b4%ec%9d%b8-10%eb%8c%80-%eb%8c%80/" target="_blank" rel="noopener">리비안과 카바나는 지난주 최고의 성과를 보인 10대 대형주 중 일부 (6월 23일-6월 29일)</a></li>
</ul>
촬영: Shutterstock의 Lutsenko_Oleksandr

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
<ol>
<li>리비안 오토모티브(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>)는 회사가 생산량을 단순화하고 비용을 절감했으며 <a href="https://www.benzinga.com//node/39497161" target="_blank" rel="noreferrer noopener">폭스바겐과의 합작</a> 투자 계획을 발표했다는 보도가 나온 후 지난주 주가가 30.04% 급등했다.</li>
<li>카니발(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUK#NYSE">CUK</a>)의 주식은 <a href="https://www.benzinga.com//node/39481992" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">2분기 실적이 예상을 상회하는 결과</a>가 나타나자 17.78% 상승했다.</li>
<li>페덱스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>)의 주식은 예상보다 나은 4분기 재무 결과와 지침으로 인해 지난주 17.51% 급등했다. 또한 이 회사는 FY25에 <a href="https://www.benzinga.com//node/39504381" target="_blank" rel="noreferrer noopener">25억 달러</a> 상당의 주식을 다시 매입할 것이라고 발표했다. 몇몇 분석가들은 주식에 대한 <a href="https://www.benzinga.com//node/39509568" target="_blank" rel="noreferrer noopener">목표</a> 가격 예측을 높였다.</li>
<li>삼사라(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>)의 주식은 RBC 캐피털(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJ#NYSE">RJ</a>)가 <a href="https://www.benzinga.com/quote/iot/analyst-ratings" target="_blank" rel="noreferrer noopener">47달러의</a> 목표 주가를 유지하고 아웃퍼폼(Outperform) 평가를 재확정함에 따라 16.37% 상승했다.</li>
<li>수자노(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUZ#NYSE">SUZ</a>)의 주식은 인터내셔널 페이퍼(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>)의 인수 추진을 <a href="https://www.benzinga.com//node/39519611" target="_blank" rel="noreferrer noopener">중단했다는 소식</a> 이후 12.24% 치솟았다.</li>
<li>카바나(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>)의 주식은 지난 <a href="https://www.benzinga.com//node/39509401" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">6월 초</a> 윌리엄 블레어(William Blair) 제 44회 연론회에서 자체 운영 계획과 자본 구조에 대한 업데이트 이후 11.93% 상승했다.</li>
<li>FTAI 에비에이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>)의 주식은 지난주 11.55% 상승했다.</li>
<li>레딧(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NASDAQ">RDDT</a>)의 주식은 <a href="https://www.benzinga.com//node/39494776" target="_blank" rel="noreferrer noopener">자동화된 웹 스크래핑을 차단하기 위한</a> 정책 업데이트를 발표한 후 11.08% 급등했다.</li>
<li>몽고DB(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>)의 주식은 지난주 10.57% 상승했다.</li>
<li>앨라일람 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>)의 주식은 회사가 부트리시란(vutrisiran)에 대한 HELIOS-B 3상 연구의 최고 결과를 발표한 후 지속적인 강세가 예상되는 가운데 주가는 10.82% 상승했다. 또한, 다수의 분석가들은 주식에 대한 전망 가격을 <a href="https://www.benzinga.com/quote/alny/analyst-ratings" target="_blank" rel="noreferrer noopener">상향 조정</a>했다.</li>
</ol>
다음 내용 읽기:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/06/39565694/moderna-and-walgreens-boots-alliance-were-among-the-10-biggest-large-cap-losers-last-week-june-23-">모더나와 월그린스 부츠는 지난주 최악의 성과를 보인 10대 대형주 중 일부 (6월 23일-6월 29일)</a></li>
</ul>
리비안의 사진

지난주 성과가 가장 나쁜 대형 주식 10개입니다. 여러분의 포트폴리오에도 들어 있나요?
<ol>
<li>EPAM 시스템즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>)의 주가는 FY24 <a href="https://www.benzinga.com//node/38732658" target="_blank" rel="noreferrer noopener">매출 전망</a>을 낮춘 후 24.6% 하락했다. 몇몇 분석가들은 주식의 <a href="https://www.benzinga.com/quote/epam/analyst-ratings" target="_blank" rel="noreferrer noopener">목표</a> 가격을 하향 조정했다.</li>
<li>쇼피파이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>)의 주가는 FY24 <a href="https://www.benzinga.com//node/38703997" target="_blank" rel="noreferrer noopener">1분기</a> 실적 이후 24.4% 하락했다. 많은 분석가들은 수익 발표 이후 쇼피파이의 <a href="https://www.benzinga.com//node/38729578" target="_blank" rel="noreferrer noopener">목표</a> 가격을 수정했다.</li>
<li>로블록스 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>)의 주가는 <a href="https://www.benzinga.com//node/38730781" target="_blank" rel="noreferrer noopener">약한 지침</a>을 발표한 후 20.5% 급락했다. 몇몇 분석가는 주식의 <a href="https://www.benzinga.com//node/38762725" target="_blank" rel="noreferrer noopener">목표</a> 가격을 낮췄습니다.</li>
<li>빌더스 퍼스트소스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>)의 주가는 <a href="https://www.benzinga.com//node/38676974" target="_blank" rel="noreferrer noopener">1분기 실적</a>에 이어 15.7% 하락했다. 일부 분석가는 주식의 <a href="https://www.benzinga.com/quote/bldr/analyst-ratings" target="_blank" rel="noreferrer noopener">목표</a> 가격을 낮췄다.</li>
<li>팔란티어 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)의 주가는 <a href="https://www.benzinga.com//node/38653781" target="_blank" rel="noreferrer noopener">약한 연간 매출 지침</a>에 따라 15.5% 하락했다. 많은 분석가들이 주식의 <a href="https://www.benzinga.com/quote/pltr/analyst-ratings" target="_blank" rel="noreferrer noopener">목표</a> 가격을 수정했다.</li>
<li>아스테라 랩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>)의 주식은 <a href="https://www.benzinga.com/pressreleases/24/05/b38681326/astera-labs-announces-financial-results-for-the-first-quarter-of-fiscal-year-2024" target="_blank" rel="noopener">1분기 실적</a>을 발표한 후 13% 급락했다.</li>
<li>수자노 S.A.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUZ#NYSE">SUZ</a>)의 주가는 인터내셔널 페이퍼에 인수 제안과 부진한 FY24 <a href="https://www.benzinga.com//node/38747815" target="_blank" rel="noreferrer noopener">1분기</a> 실적 보고서에 따라 13.98% 하락했다.</li>
<li>텔레포니카 브라질 S.A.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIV#NYSE">VIV</a>)의 주가는 회사가 1분기 재무 결과를 보고하고 <a href="https://www.benzinga.com/quote/viv/analyst-ratings" target="_blank" rel="noreferrer noopener">분석가들이 목표 가격</a>을 낮춘 후 11.8% 하락했다.</li>
<li>에어비앤(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>)의 주식은 회사가 1분기 실적을 <a href="https://www.benzinga.com//node/38713550" target="_blank" rel="noreferrer noopener">발표</a>한 후 9.3% 하락했다. 많은 애널리스트들이 <a href="https://www.benzinga.com//node/38735131" target="_blank" rel="noreferrer noopener">목표 주가</a>를 조정했다.</li>
<li>월트 디즈니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>)의 주식은 예상보다 낮은 <a href="https://www.benzinga.com//node/38669929" target="_blank" rel="noreferrer noopener">2분기 매출</a>을 발표한 후 7.3% 하락했다. 몇몇 애널리스트들이 이 주식에 대한 <a href="https://www.benzinga.com/quote/dis/analyst-ratings" target="_blank" rel="noreferrer noopener">목표 주가</a>를 낮췄다.</li>
</ol>
이 기사도 읽어보기: <a href="https://www.benzinga.com/news/24/05/38779419/these-10-large-cap-stocks-shined-brightest-last-week-may-5-may-11-2024-are-they-in-your-portfolio">지난 주에 가장 밝은 모습을 보인 대형 기업 10개 (5월 5일~11일) 당신의 포트폴리오에 있나요?</a>
사진: 셔터스톡

Comments

Suzano

뉴스

에 대한 최신 뉴스 Suzano (NYSE:SUZ) 주식

일요일, 6월 08, 2025

일요일, 6월 30, 2024

일요일, 5월 12, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌